Placement Agent Agreement Alien Technology Corporation & Advanced Equities, Inc.
Exhibit 10.44
Placement Agent Agreement
Alien Technology Corporation & Advanced Equities, Inc.
Alien Technology Corporation, a Delaware corporation (the “Company”), hereby engages Advanced Equities, Inc., an Illinois corporation (“PA”), to assist the Company in obtaining financing through a private placement, between the date of this Agreement and March 24, 2005, of the Company’s Series C, Series D, Series E, Series F and Series G Preferred Stock (the “Preferred Shares”) described in the attached Exhibit B (the “Financing”) as follows:
1. Services.
(a) PA shall offer participation in the Financing to potential investors which PA reasonably believes are “accredited investors” as defined by Regulation D. Any potential investor in the Financing first introduced by PA to Company will be set forth on Exhibit A-1 (each, a “Qualified Investor”); provided, however, Qualified Investors shall not include persons that are stockholders of the Company on the date of this Agreement or those entities set forth on Exhibit A-2.
(b) PA acknowledges that (i) the Company is free to contact potential investors directly and engage other agents on its behalf, (ii) the Company may determine, in its sole discretion, whether to accept an offered investment by a Qualified Investor and (iii) the Company is not obligated to compensate PA for investments offered to the Company that the Company does not accept. However, the Company is obligated to accept investments in the Financing in the aggregate amount up to $6.855 million from Qualified Investors that (x) have completed the suitability questionnaire in a form similar to Exhibit C and (y) the Company determines, in its reasonable discretion based on such suitability questionnaires, are accredited investors.
2. Compensation.
(a) Cash Compensation. The Company shall pay PA, as partial compensation for the services provided by PA hereunder, a cash fee (the “Cash Fee”) equal to 0.05 of the funds invested.
(b) Warrant Compensation. The Company shall issue PA, as the remainder of the compensation for the services provided by PA hereunder, a warrant (the “Warrant Fee” and with the Cash Fee, collectively, the “Fee”) in the form of the Warrant Agreement attached as Exhibit D. The Warrant Agreement will be exercisable for that number of shares of Common Stock of the Company equal to the product of the number of shares of Preferred Shares sold in the Financing to Qualified Investors and 0.05. In order for shares to be considered sold under this Section 2(b), the Company or its designated agent must have accepted possession of the applicable investment funds.
3. Term.
(a) Term. Unless and until terminated as set forth herein, this Agreement will continue in full force and effect for an initial term expiring at the earlier of: (i) the final closing of the Financing; or (ii) March 24, 2005; provided, however, Sections 6, 7 and 8 shall survive the termination of this Agreement.
(b) Renewal. Upon expiration of this Agreement pursuant to Section 3(a)(ii), the Company may renew this Agreement on a month-to-month basis by notice to PA at least 30 days prior to such expiration.
(c) Termination. (i) The Company may terminate this Agreement immediately and without notice in the event of breach by PA of this Agreement, and (ii) either party may terminate this Agreement upon 30 days’ prior written notice to the other party for any reason other than breach by PA of this Agreement. In the event the Company terminates this Agreement pursuant to Section 3(c)(i), PA will not be entitled to any unpaid Fee and the Company will be entitled to all other remedies available under applicable law. In the event the Company terminates this Agreement pursuant to Section 3(c)(ii), PA will be entitled to the Fee with respect to approved Qualified Investors if the Financing closes on or before March 24, 2005.
4. Performance. In connection with the performance of its duties under this Agreement, PA agrees as follows:
(a) PA shall act in a manner consistent with the instructions of the Company and comply with all applicable laws, whether foreign or domestic, of each jurisdiction in which PA proposes to carry on the business contemplated by this Agreement. PA shall not take any action or omit to take any action that would cause the Company to violate any law or any applicable exemption from registration under the Securities Act or the Securities Exchange Act.
(b) PA shall consecutively number each copy of the Company’s Confidential Private Placement Memorandum, as may be supplemented from time to time (the “Memorandum”), provided to it by the Company and shall not distribute copies of any single numbered Memorandum to more than one potential investor. For each numbered Memorandum, PA shall keep a record of when and to whom such Memorandum is given. If PA delivers the Memorandum via electronic mail, PA shall send the Memorandum in the form of an Adobe Portable Document Format, cause the cover message to contain a legend stating that neither the message nor any of its contents or attachments may be forwarded, copied or disseminated to anyone other than the recipient’s attorney or a similar advisor bound by confidentiality, and maintain a copy of the cover message.
(c) PA shall provide the Company with a copy of each such record upon request by the Company’s counsel for compliance with applicable law or in response to judicial or administrative process.
(d) PA shall not make any untrue statement of a material fact or omit to state any fact necessary to make any statement made not misleading. PA shall provide information regarding the Company only as contained in the Memorandum.
(e) PA shall not engage in any form of general solicitation or general advertising. For example PA shall not mention the Company in any public medium without the written permission of the Company.
(f) Before mentioning or sending any material related to the Company to any potential investor, PA shall, on the basis of PA’s prior relationship with the potential offeree, reasonably believe that the potential offeree is: (x) an “accredited investor” and (y) so sophisticated
-2-
and knowledgeable in business and financial matters that the potential offeree is capable of evaluating the merits and risks of an investment in the Company.
(g) PA shall cause its employees and affiliates to comply with all of the foregoing provisions of this Section 4.
5. Representations and Warranties.
(a) PA represents and warrants that PA has and will maintain during this Agreement all licenses, registrations, permits and other authorizations required for PA to perform the activities and receive the compensation contemplated by this Agreement in each jurisdiction in which PA proposes to engage in such activities. In particular, but without limiting the generality of the foregoing, PA is and will be duly licensed or registered as a broker dealer or registered representative of a broker dealer under the Exchange Act and under the laws of each jurisdiction requiring such licensing or registration.
(b) The Company represents and warrants that the Memorandum, as amended or supplemented by any other written materials delivered to a Qualified Investor before the Company accepts that Qualified Investor’s investment, contains and will contain no misrepresentation of a material fact, and does not and will not omit a material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made, provided that PA has promptly transmitted to any Qualified Investor whose proposed investment the Company has not yet accepted a copy of any such amendment or supplement to the Memorandum.
6. Indemnification.
(a) The Company agrees to indemnify and hold harmless PA, its officers, directors, employees, legal counsel and its affiliates (each, a “PA Indemnified Party”) against any and all losses, claims, damages, liabilities, joint or several, and expenses (including all legal or other expenses reasonably incurred by a PA Indemnified Party) caused by or arising out of (i) any misrepresentation or untrue statement or alleged misrepresentation or untrue statement of a material fact made by the Company, its officers or representatives to PA, or the omission or the alleged omission to state to PA a material fact necessary in order to make statements made not misleading in light of the circumstances under which they were made (except to the extent such misrepresentations, untrue statements or omissions are based on information provided to the Company by PA), or (ii) any misrepresentation or untrue statement or alleged misrepresentation or untrue statement of a material fact contained in any document furnished to the Qualified Investors, or the omission or the alleged omission to state in the documents furnished to the Qualified Investors a material fact necessary in order to make the statements therein not misleading in light of the circumstances under which they were made, to the extent such misstatements or omissions are made in reliance upon and in conformity with written information furnished by the Company for use in the documents furnished to the Qualified Investors. The Company agrees to reimburse the PA Indemnified Party for any reasonable expense (including reasonably fees and expenses of counsel) incurred as a result of producing documents, presenting testimony or evidence, or preparing to present testimony or evidence (based upon time expended by the PA Indemnified Party at its then current time charges or if such person shall have no established time charges, then based upon reasonable charges), in connection with any court or administrative proceeding (including any
-3-
investigation which may be preliminary thereto) arising out of or relating to the performance by the PA Indemnified Party or any obligation hereunder. The Company’s obligations under this Section 6(a) shall be limited to the net amount of funds received from investors on which the Company paid a fee to PA.
(b) PA agrees to indemnify and hold harmless the Company, its officers, directors, employees, legal counsel and its affiliates (each, a “Company Indemnified Party”) against any and all losses, claims, damages and liabilities, joint or several, and expenses (including all legal or other expenses reasonably incurred by a Company Indemnified Party) caused by or arising out of (i) any misrepresentation or untrue statement or alleged misrepresentation or untrue statement of a material fact made by PA to the Qualified Investors, or the omission or the alleged omission to state to the Qualified Investors a material fact necessary in order to make statements made not misleading in light of the circumstances under which they were made (except to the extent such misrepresentations, untrue statements or omissions are based on information provided to PA by the Company), (ii) any misrepresentation or untrue statement or alleged misrepresentation or untrue statement of a material fact contained in any document furnished to the Qualified Investors, or the omission or the alleged omission to state in the documents furnished to the Qualified Investors a material fact necessary in order to make the statements therein not misleading in light of the circumstances under which they were made, to the extent such misstatements or omissions are made in reliance upon and in conformity with written information furnished by PA for use in the documents furnished to the Qualified Investors, (iii) any breach or alleged breach of any representation, warranty or covenant made by PA in this Agreement, or (iv) PA’s bad faith, gross negligence or willful misconduct in performing the services described herein. PA agrees to reimburse the Company Indemnified Party for any reasonable expense (including reasonable fees and expenses of counsel) incurred as a result of producing documents, presenting testimony or evidence, or preparing to present testimony or evidence (based upon time expended by the Company Indemnified Party at its then current time charges or if such person shall have no established time charges, then based upon reasonable charges), in connection with any court or administrative proceeding (including any investigation which may be preliminary thereto) arising out of or relating to the performance by the Company Indemnified Party of any obligation hereunder. PA’s obligations under this Section 6(b) shall be limited to the amount of the Fee paid to it by the Company.
(c) This Section 6 will survive expiration or termination of this Agreement.
7. Confidentiality. PA will maintain in confidence and will not use for its own benefit or other than for the performance of its obligations under this Agreement: any inventions, confidential know-how, trade secrets and other non-public information and data disclosed to it by the Company, and it will not divulge the same to any other persons until such time as the information becomes a matter of public knowledge. This Section 7 will survive expiration or termination of this Agreement.
8. Purchase and Sale of Secondary Interests of the Company. Commencing March 25, 2005 and continuing through the earlier of (i) January 25, 2007 or (ii) closing of the sale of the Company’s Common Stock pursuant to a registration statement filed by the Company under the Securities Act, in connection with the first underwritten offering of the Company’s securities to the general public, neither PA nor its officers, directors, employees or affiliates will engage in brokering
-4-
or dealing (or participate in any discussions regarding the brokering or dealing, other than discussions with the Company) of secondary interests of the Company, or otherwise purchase secondary interests of the Company, from any individual, entity or group. This Section 8 will survive expiration or termination of this Agreement.
9. Expenses. The Company shall, promptly following the final closing of the Financing, pay PA (i) its actual legal fees and expenses (up to a maximum of $25,000) incurred in connection with fulfilling its obligations under this Agreement; and (ii) its other reasonable out-of-pocket expenses (up to a maximum of $10,000) incurred in connection with fulfilling its obligations under this Agreement; provided, however, that the Company shall have no such obligation to pay PA until PA provides the Company reasonably detailed invoices that set forth the fees and expenses in (i) and (ii). PA will not be reimbursed for any other expenses it incurs in connection with fulfilling its obligations under this Agreement.
10. Independent Contractor. PA will perform its services hereunder as an independent contractor, and nothing in this Agreement will in any way be construed to constitute PA the agent, employee or representative of the Company. Neither PA nor any agent acting on behalf of PA will enter into any agreement or incur any obligations on the Company’s behalf or commit the Company in any manner or make any representations, warranties or promises on the Company’s behalf or hold itself (or allow itself to be held) as having any authority whatsoever to bind the Company without the Company’s prior written consent, or attempt to do any of the foregoing.
11. General.
(a) Arbitration. Except as otherwise provided by law, the parties hereto agree that any dispute or controversy arising out of, relating to or concerning any interpretation, construction, performance or breach of this Agreement, shall be settled by arbitration to be held in Santa Clara County, California, in accordance with the commercial dispute resolution rules then in effect of the American Arbitration Association. The arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator will be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. The parties shall each pay one-half of the costs and expenses of such arbitration, and each shall separately pay its counsel fees and expenses.
(b) Covenant against Assignment. This Agreement is personal to the parties hereto, and accordingly neither the Agreement nor any right hereunder or interest herein may be assigned or transferred or charged or otherwise dealt with by either party without the express written consent of the other. Notwithstanding the foregoing, however, the Company will be entitled to assign this Agreement and the Company’s rights hereunder to a successor to all or substantially all of its assets, whether by sale, merger or otherwise.
(c) Entire Agreement; Amendment. This Agreement and the attached exhibits constitute the entire contract between the parties with respect to the subject matter hereof and supersede any prior agreements between the parties. Notwithstanding the forgoing, Company and PA agree that nothing in this Agreement effects the rights or obligations of the parties with respect to their Placement Agent Agreement dated July 25, 2003 (“PA Agreement”) relating to the sale of certain shares of Company’s Series F Preferred Stock, including without limitation PA’s rights under
-5-
the terms of such PA Agreement to participate in Company’s underwriting syndicate as the seller of up to 7% of the shares of Company in its initial public offering. This Agreement may not be amended, nor any obligation hereunder waived, except by an agreement in writing executed by, in the case of an amendment, each of the parties hereto, and, in the case of a waiver, by the party waiving performance.
(d) No Waiver. The failure or delay by a party to enforce any provision of this Agreement will not in any way be construed as a waiver of any such provision or prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted both parties hereunder are cumulative and will not constitute a waiver of either party’s right to assert any other legal remedy available to it.
(e) Severability. Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions will nevertheless remain effective and will remain enforceable to the greatest extent permitted by law.
(f) Notices. Any notice, demand, offer, request or other communication required or permitted to be given by either the Company or PA pursuant to the terms of this Agreement must be in writing and will be deemed effectively given the earlier of (i) when received, (ii) when delivered personally, (iii) one business day after being delivered by facsimile (with receipt of appropriate confirmation) to the number provided to the other party or such other number as a party may request by notifying the other in writing, (iv) one business day after being deposited with an overnight courier service or (v) four days after being deposited in the U.S. mail, First Class with postage prepaid, and addressed to the party at the address previously provided to the other party or such other address as a party may request by notifying the other in writing.
(g) Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same agreement. Facsimile copies of signed signature pages will be deemed binding originals.
-6-
The parties have executed this Placement Agent Agreement as of March 28, 2005.
| ALIEN TECHNOLOGY CORPORATION |
| /s/ Ronald Shelton |
| Signature of Authorized Signatory |
| Ronald Shelton, CFO |
| Name and Title of Authorized Signatory |
| PLACEMENT AGENT |
| Name of PA |
| /s/ Dwight O. Badger |
| Signature of Authorized Signatory |
| Dwight O. Badger, CEO |
| Name and Title of Authorized Signatory |
-7-
Exhibit A-1
QUALIFIED INVESTORS
| Name and Address of Qualified Investor | Company Initialed Approval | |||
| 1. | Advanced Equities Investments XX, LLC | Approved ¨ | ||
| 311 S. Wacker, Suite 1650 | ||||
| Chicago, IL 60606 | ||||
| 2. | BTB LLC | Approved ¨ | ||
| c/o Advanced Equities, Inc. | ||||
| 311 S. Wacker, Suite 1650 | ||||
| Chicago, IL 60606 | ||||
| 3. | GG, LLC | Approved ¨ | ||
| c/o Advanced Equities, Inc. | ||||
| 311 S. Wacker, Suite 1650 | ||||
| Chicago, IL 60606 | ||||
| 4. | Lake Michigan Investments II, LLC | Approved ¨ | ||
| c/o Advanced Equities, Inc. | ||||
| 311 S. Wacker, Suite 1650 | ||||
| Chicago, IL 60606 | ||||
| 5. | Randolph Associates | Approved ¨ | ||
| c/o Advanced Equities, Inc. | ||||
| 311 S. Wacker, Suite 1650 | ||||
| Chicago, IL 60606 | ||||
Exhibit A-2
Shareholders Not Introduced to Company By PA
| John Stephen Smith |
| Jack Carsten |
| Mark Hadley |
| Amnon Yariv |
| Randy Bartman |
| Bill and Nancy Lowe |
| Frank Lowe |
| John Stuart Lowe-Smith |
| Donald T. Aanestad |
| Collier Buffington |
| Gordon S. Craig |
| Richard A. Flasck |
| Sangtae Kim |
| Veronica Lopez |
| Paul Nealey |
| Tom Nolan |
| William G. Oldham |
| George H. Schneer |
| John T. Velcamp |
| Howard M. Bailey |
| Alan V. King |
| Michelle Swenson And Stan Drobac Rev. Trust Dtd 6/8/95 |
| Donald A. Lee |
| Arno Penzias |
| Pamela Miguel |
| William H. Joseph |
| Al Joseph |
| Charlie Bass, Trustee, The Bass Trust UTD 4/29/88 |
| The Carsten 1978 Trust, As Amended UTA 7/12/78, Jack C. Carsten, Trustee |
| Neil Chlarson |
| Dennis DeCoste |
| Charles C. Harwood |
| Alan V. King & Carolyn B. King Trustees UDT 8/12/86 |
| Patterson Family Trust |
| Paul R. Patterson Irrevocable Trust |
| Steven C. Patterson Irrevocable Trust |
| George H. Schneer & Lois F. Schneer, Co-Trustees of the Schneer Living Trust dated October 1, 1982, as amended |
| Richard J. Schoofs |
| Johannes C. Severiens, Jr. Trust U/D/T dated February 1, 2004, Annette Severiens, Successor Trustee |
| University of Wisconsin Foundation |
| Lida Urbanek, Trustee of the Lida Urbanek Revocable Trust dated 6/28/95 |
| Samuel Urcis |
| Bernard Vonderschmitt |
| WS Investment Company 95A |
| Danielle Yariv |
| Dana Yariv Irrevocable Trust |
| Gabriela Yariv |
| CMEA Ventures II, L.P. |
| Dow Chemical Company |
| David and Valerie Estes |
| Thomas Lawrence |
| Mill Valley Partners |
| Gregory R. Schoofs |
| Sevin Rosen VI Affiliates Fund L.P. |
| Sevin Rosen Fund VI L.P. |
| Sunrise Capital Fund I, LLC |
| BVCF IV, L.P. |
| Dr. Jean M.J. Frechet |
| NEA Presidents Fund, L.P. |
| NEA Ventures 1999, L.P. |
| New Enterprise Associates VIII, L.P. |
| Sevin Rosen Bayless Management Company |
| Neil Wolff |
| Allen & Company, Inc. |
| Avery Dennison Corporation |
| Digital BandWidth LLC |
| DuPont Chemical and Energy Operations, Inc., a wholly owned subsidiary of DuPont |
| Equitek Bridge Ltd. |
| Beagle Limited |
| Jack C. Provine & Janice E. Provine, Trustees of the Provine Family Revocable Trust, RTA August 1, 1999 |
| Rho Management Trust I |
| Robert W. Shapiro and Peggy Y. Shapiro, Trustees for the Shapiro Family Revocable Trust dated November 30, 1990 |
| Stephen Berke |
| Yoco Partners LLC |
| Philips Venture Capital Fund, BV |
| Comdisco, Inc. |
| Silicon Valley Bank |
| Ronald Nowicki |
| Hemant T. Sathe |
| DVI Financial Services, Inc. |
| Miroslav Anic |
| Kathleen A. Wilkerson |
| Quan Ventures, L.P. (Delaware) |
| Quan Ventures, L.P. (BVI) |
| Eric S. Dobkin Charitable Remainder Trust |
| Lior Bregman |
| Emigrant Capital Corporation |
| Northwestern University |
| Nicholas Guerra |
| Daniel and Margaret Seligson Trust UAD 3/27/97 |
| Toray International Inc. |
| Jay Furman |
| Richard Goldberg |
| Qventures KG |
| TeKBanC Limited |
| Infrastructure and Environmental Private Equity Fund III, L.P. |
| Environmental and Information Technology Private Equity Fund III |
| The Productivity Fund IV, L.P. |
| The Productivity Fund IV Advisors Fund, L.P. |
| Janos Czukor |
| Mohammad Zaher |
| Jean-Pierre Gloton |
| Paul Intrieri |
| Firstcorp Funding III |
| Roehl Pagala |
| University of California Berkeley |
| TBCC FUNDING TRUST II |
| Stan Drobac |
| WS Investment Company 99A |
| WS Investment Company 2000A |
| Glenn Gengel |
| Bruce Dougan |
| Randolph Eisenhardt |
| Nicole Talesfore |
| Louis Kan |
| Roger Stewart |
| Anno Hermanns |
| New Enterprise Associates 8A, Limited Partnership |
| Battelle Memorial Institute |
| Jay Tu |
| Robert & Susan Robert Abramowitz and Susan Stewart |
| IDEO Product Development, Inc. |
| UPM-Kymmene Corporation |
| Equitek Global Technology Fund, L.P. |
| Equitek Global Technology Fund (Cayman) |
| Equitek Bridge II Limited |
| Jan Bernkopf |
| Robert W. Shapiro |
| Jack C. Provine |
| Omar Alvarado |
| Teresa Gruber |
| Tuyen Tran |
| Jane Ellis |
| Brian Hoobler |
| Frank Cuomo |
| James Atherton |
| Tom Credelle |
| Robert A. Buchman |
| John H. Patton |
| Debra E. Keller |
| John Simon |
| Michael Mcgregor |
| Elena DeCoste |
| Corinne DeCoste |
| Andrew Niu |
| Arcadio Mariano |
| Dahlia Tobias |
| Erlinda Chartrand |
| Trish McCall |
| William G. Murphy |
| Najib Kahn |
| Brian Daley |
| Barbara Martinez-Smith |
| Mary Piasecki |
| Alice Olmeda-Young |
| Jun Liu |
| Hoang Pham |
| Sherry Dykes |
| Frederic Vincentini |
| Wolff Trust UDT 5/25/02 |
| Yihan Shi |
| Duy Phach Vu |
| Anne Chiang |
| Sean Pearson |
| Elaine Yau |
| Heller Financial Leasing, Inc. |
| Keystone European Equity Investments Limited |
| Marla Abeyta |
| Mark Berry |
| Fred Patton |
| Stav Prodromou |
| The Gillette Company |
| Manhattan Associates, Inc. |
| Lago Ventures Fund One Limited |
| Eric S. Dobkin |
| Sevin Rosen Fund VIII L.P. |
| Sevin Rosen VIII Affiliates Fund L.P. |
| WS Investment Company, LLC |
| Jeffery Jacobsen |
| Larry Hennick |
| Tanlin Dickey |
| Patricia Lou Rogness Smith |
| Oscar R. Rodriguez |
| Shirley Kim |
| Scott Family Living Trust |
| John M. Hemingway |
| David Aaron |
| Paul Drziac |
| Robert Martin |
| Michael A. Allocco |
| Kelly Merritt |
| David Norval |
| Michael Schnoll |
| Greg Wimble |
| Scott Herrmann |
| David Bledsoe |
| Christopher Parkinson |
| Mike Gallagher |
| Cornelius Sutu |
| Kimberly Wilson |
| Ronald Gilbert |
| Samuel Warner |
| Susan Pearson |
| Hans-Rudolph Wickler |
| Theresa Bruno |
| Charles C. Hamilton |
| Bradley Bank Associates, LLC |
| Miami Valley Venture Fund I & II L.P. |
Placement Agent Agreement
Alien Technology Corporation & Advanced Equities, Inc.
Exhibit B
SUMMARY OF TERMS
ALIEN TECHNOLOGY CORPORATION
SUMMARY OF TERMS OF THE FOURTH CLOSING OF THE
SERIES G PREFERRED STOCK FINANCING, INCLUDING THE SALE OF SHARES OF
CERTAIN OTHER SERIES OF PREFERRED STOCK
This proposed summary of terms relates to the proposed placement, between December 9, 2004 and March 24, 2005, of shares of Series C, Series D, Series E, Series F and Series G Preferred Stock of Alien Technology Corporation by Advanced Equities, Inc. (“AEI”). This term sheet is to be used as the basis for preparation of definitive offering documents and other documentation to be executed and delivered in connection with this placement and there is no obligation on the part of any negotiating party until such definitive documentation is signed by all parties. This term sheet is non-binding does not constitute either an offer to sell or an offer to purchase securities.
| Issuer: | Alien Technology Corporation, a Delaware corporation (the “Company”). | |
| Type of Security: | Series C, Series D, Series E, Series F and Series G Preferred Stock (the “Preferred Shares”). | |
| Amount: | $6,855,000 | |
| Price Per Share: | $3.00 | |
| Closing Date: | The closing date of the sale of Preferred Shares will be between December 9, 2004 and March 24, 2005. | |
| Use of Proceeds: | The net proceeds from the sale of the Preferred Shares will be used primarily for working capital and general corporate purposes. | |
| Series G Preferred Relationship to Other Series of Preferred Stock: | The Company has six other series of Preferred Stock. The Series G Preferred Stock (the “Series G Preferred”) will rank on parity in all rights with the Series F Preferred Stock (the “Series F Preferred”) but reflect the difference in price paid per share. | |
| Rights, Preferences, Privileges and Restrictions of Other Preferred Shares: | The rights, preferences, privileges and restrictions of all Preferred Shares (other than the Series G Preferred) to be sold by the Company in this placement will be as stated in the Company’s Certificate of Incorporation, Registration Rights Agreement, Stockholders Agreement and Voting Agreement, each as amended from time to time. | |
| Dividends: | If and when declared by the Board of Directors, the Series G Preferred will be paid dividends at a rate of 8% of the purchase price per share ($0.24 per share). | |
| Liquidation Preference: | In the event of any liquidation, dissolution or winding up of the Company, holders of the Series G Preferred and the Series F Preferred will be entitled to an amount equal to 50% times the respective purchase price per share of such Preferred Stock, plus any accrued but unpaid dividends thereon before any payments are made to holders of classes of Preferred Stock prior to the Series F Preferred or Common Stock of the Company.
Any remaining amounts will be distributed ratably to all preferred stockholders on an as-converted basis until such time as all preferred stockholders have received an amount equal to one times the purchase price per share of such Preferred Stock plus any accrued but unpaid dividends (it being understood that one times the purchase price of the Series G Preferred and Series F Preferred shall include the liquidation preference provided in the first paragraph of this Liquidation Preference section).
Any remaining amounts will be distributed ratably to all stockholders on an as-converted basis; provided, however, that the preferred stockholders shall stop participating pursuant to this third paragraph when they have received an amount equal to two times the purchase price per share of such Preferred Stock plus any accrued but unpaid dividends (including the liquidation preference provided in the first and second paragraphs of this Liquidation Preference section). An acquisition of the Company in which its stockholders immediately prior to such event do not own a majority of the outstanding shares of the surviving corporation or the sale of all or substantially all of the assets of the Company, will be treated as a liquidation (collectively, a “Liquidation Event”). | |
| Conversion/Antidilution: | Series G Preferred will be convertible in whole or in part, initially on a one-for-one basis, into shares of Common Stock.
The conversion price of the Series G Preferred will be subject to adjustment to prevent dilution in the event that the Company issues additional shares (other than (i) shares issued upon exercise of stock options that are approved by the Board of Directors and are issued pursuant to the Company’s stock option plan, (ii) shares issued in public offerings, (iii) shares issued in acquisitions of other companies, (iv) shares issued in lease or loan transactions and (v) shares issued in connection with conversion of Preferred | |
| Stock) at a purchase price less than the Series G Preferred original purchase price. In such event, the conversion price will be adjusted on a weighted average basis pari-passu with Series A, B, C, D, E and F. There will also be proportional adjustments for stock splits, stock dividends, reclassifications and the like. | ||
| Automatic Conversion: | The Preferred Stock will be automatically converted into Common Stock of the Company, at the then applicable conversion price, (i) upon the closing of a sale of the Company’s shares of Common Stock pursuant to a firm commitment underwritten public offering by the Company at a market capitalization of not less than $250,000,000 with proceeds (prior to underwriter commissions and discounts) equal to or greater than $25,000,000 or (ii) with the written consent of a majority of all Preferred Stock. | |
| Voting Rights: | Except as otherwise required by law or as provided herein, holders of Series G Preferred shall have a number of votes equal to the number of shares of Common Stock into which their Series G Shares could be converted and shall have the same voting rights as the Series F Preferred, voting together with the other shares of Preferred Stock as a single class, except as provided in the paragraph below. In addition, to the extent approval of any action by at least fifty percent (50%) of the outstanding Preferred Stock would adversely affect one series of Preferred Stock but not the other series, the adversely affected series will have a separate series vote on such action. | |
| Protective Provisions: | The holders representing at least fifty percent (50%) of the outstanding Series G Preferred, voting as a single class, will be required to approve any action that would: (i) restrict the payment of dividends on the Series G Preferred or the conversion of such stock into Common Stock; (ii) redeem any outstanding Preferred Stock; (iii) repurchase any shares of Common Stock except repurchases approved by the Board pursuant to plans or agreements with employees, directors or consultants; or (iv) declare or pay any dividend except as permitted by the Restated Certificate. | |
| Registration Rights: | Pari-passu with the Series F Preferred. | |
| Financial Information Rights: | Upon request, holders of at least 500,000 shares of Series G Preferred shall be entitled to receive from the Company:
(i) Within 90 days after the end of each fiscal year, annual financial statements prepared in accordance with GAAP, | |
| audited and certified by the Company’s independent public accountants;
(ii) Within 30 days prior to the beginning of each fiscal year, a business plan and operating budget for the next fiscal year; and
(iii) Within 45 days after the end of each quarter of each fiscal year, unaudited financial statements. | ||
| Right of First Offer: | The holders of at least 100,000 shares of Series G Preferred will have the right to participate in any future issuance of the Company capital stock upon the terms of such issuance to an extent that allows such holders to maintain their percentage ownership interests in the Company immediately prior to such issuance, subject to exceptions for issuances in connection with (i) conversions of Preferred Stock, (ii) public offerings, (iii) acquisitions of other companies, (iv) stock splits, and (v) exercises of options approved by the Board of Directors. | |
| Purchase Agreement: | The sale of the Series G Preferred will be made pursuant to a purchase agreement substantially the same as the Series F Preferred Stock Purchase Agreement in form and substance acceptable to AEI. Counsel to the Company shall draft the purchase agreement and other closing documents, with review and comment by AEI and shall provide the same type of legal opinion with regard to the offering as counsel provided in the Company’s Series F financing. | |
| Formation of LLC: | AEI shall engage their attorneys to form an LLC for investors who invest less than $1,000,000 in the offering. All such investors must be accredited for purposes of purchasing non publicly traded securities. | |
| Placement Agent Agreement: | The Company and AEI shall execute a placement agent agreement (“Placement Agent Agreement”) concurrent with the execution of this term sheet. | |
| Acknowledged and Agreed to: | Alien Technology Corporation: | |
| Stavro Prodromou |
| President and CEO |
| Advanced Equities, Inc.: |
| Dwight Badger / President |
Placement Agent Agreement
Alien Technology Corporation & Advanced Equities, Inc.
Exhibit C
SUITABILITY QUESTIONNAIRE
PURCHASER QUESTIONNAIRE
(PROVIDE ALL APPLICABLE INFORMATION)
(Please print or type)
Size of Investor Member Interest :
Purchaser Information:
Name of Individual or Entity:
Federal Tax ID or Social Security Number:
Marital Status (Natural Persons): Date of Birth:
Citizen of or State of Organization:
Principal Address:
| (street) |
____________________________________________________________________________________________
| (city) (state) (zip) |
Telephone Number:
Mailing Address:
(if different) (street)
____________________________________________________________________________________________
(city) (state) (zip)
Co-Purchaser Information:
Name of Individual or Entity:
Federal Tax ID or Social Security Number:
Marital Status (Natural Persons): Date of Birth:
Citizen of or State of Organization:
Principal Address:
(street)
____________________________________________________________________________________________
(city) (state) (zip)
Telephone Number:
Mailing Address:
(if different) (street)
___________________________________________________________________________________________
(city) (state) (zip)
Indicate Type of Ownership:
| ¨ | Individual | ¨ | Keogh Plan | |||
| ¨ | Tenants by the Entireties* | ¨ | Trust | |||
| ¨ | Joint tenants with Rights of Survivorship* | ¨ | Partnership | |||
| ¨ | Community Property* | ¨ | Limited Liability Company | |||
| ¨ | Tenants in Common* | ¨ | Corporation | |||
| ¨ | Individual Retirement Account (IRA)* (signature of Custodian also required) | ¨ | Uniform Gift to Minors Act | |||
| ¨ | Pension Plan | State: | ||||
| Custodian’s Name: | ||||||
| Minor’s Name: | ||||||
| * | Two or more signatures required |
| 12. | [FOR INDIVIDUALS] (a) The subscriber’s gross income as evidenced by federal income tax returns for applicable years: |
| Individual | With Spouse | |||||||
| (i) | in [2002] was in excess of | $ | $ | |||||
| (ii) | in [2003] was in excess of | $ | $ | |||||
| (iii) | in [2004] is expected to be in excess of | $ | $ | |||||
(b) The subscriber’s net worth, or joint net worth with the subscriber’s spouse, is in excess of (including the value of home, home furnishings and automobiles):
$
(c) The current value of my liquid assets (cash, marketable securities, cash surrender value of life insurance and other items easily convertible into cash) is sufficient to provide for my current needs and possible personal contingencies:
Yes ¨ No ¨
| 13. | Based upon the foregoing, which of the following categories, if any, constitutes you as an Accredited Investor? |
(Initial one)
| ¨ | I have a net worth (including home, home furnishings and automobiles) either jointly or with spouse or individually in excess of $1,000,000. |
| ¨ | I have had an individual income (not including income of spouse) during the past two calendar years in excess of $200,000, or joint income with my spouse in excess of $300,000, and I reasonably expect to have income in excess of $200,000 (or joint income with my spouse in excess of $300,000) during this current calendar year. |
| ¨ | Other (for entity investors, (i) has $5,000,000 or more of assets and was not formed for the specific purpose of making this investment or (ii) all beneficial owners meet one of the above tests). |
| NOTE— | SECTION IV OF THE SUBSCRIPTION AGREEMENT MUST ALSO BE FILLED OUT IN A MANNER CONSISTENT WITH THE ABOVE |
| 14. | I have previously participated in any of the following types of investment: |
| Yes | No | |||
| Stocks | ¨ | ¨ | ||
| Bonds | ¨ | ¨ | ||
| Real Estate Limited Partnerships | ¨ | ¨ | ||
| Oil and Gas Limited Partnerships | ¨ | ¨ | ||
| Other Tax Shelters | ¨ | ¨ | ||
| Other Private Placements of Securities | ¨ | ¨ |
| 15. | If subscriber is an individual, I consider myself to be an experienced and sophisticated investor; or, if subscriber is an entity (a partnership, corporation, limited liability corporation, trust or estate), the entity considers itself to be an experienced and sophisticated investor. |
Yes ¨ No ¨
| 16. | If subscriber is an individual, I have such knowledge and experience in financial and business matters that I am capable of evaluating the risks and merits of this investment and believe that I can afford the loss of my investment in the Company; or, if subscriber is an entity, the entity has such knowledge and experience in financial and business matters that it is capable of evaluating the risks and merits of this investment and believes that it can afford the loss of its investment in the Company. |
Yes ¨ No ¨
[SIGNATURES SET FORTH ON THE FOLLOWING PAGE]
(NOTE: Signatures should conform with those used in Subscription Agreement.)
Dated: , 2004
| If an INDIVIDUAL OR JOINT TENANCY or CO-TENANCY, complete the following: | ||||
| Print name of individual or joint or co-tenant | Print name of second joint or co-tenant (if any) | |||
| Signature of individual or joint or co-tenant | Signature of second joint or co-tenant | |||
| If a PARTNERSHIP, CORPORATION, LIMITED LIABILITY CORPORATION, TRUST OR OTHER ENTITY, complete the following: | If an INDIVIDUAL RETIREMENT ACCOUNT | |||
| Capacity of authorized Signatory | Print name of Beneficiary | |||
| Title of Entity | (Signature of Custodian) | |||
| Name of Broker Dealer Selling Interest: | ||||
| Signature of authorized Signatory | ||||
| (Signature of Broker Dealer Representative) | ||||
| Print Name of Representative | ||||
Placement Agent Agreement
Alien Technology Corporation & Advanced Equities, Inc.
Exhibit D
WARRANT AGREEMENT
THE SECURITIES EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF SUCH SECURITIES REASONABLY SATISFACTORY TO THE COMPANY STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.
| Date of Issuance: March 24, 2005 | Number of Shares: | |
| (subject to adjustment) |
WARRANT TO PURCHASE STOCK
of
ALIEN TECHNOLOGY CORPORATION
(void after March 24, 2010)
1. Number of Shares Subject to Warrant. ALIEN TECHNOLOGY CORPORATION (the “Company”), for value received, hereby certifies that AEI Holding Corporation, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms set forth below, to purchase from the Company the amount and kind of shares of the Company, at a purchase price per share, subject to adjustment as hereinafter provided, upon the occurrence of certain events, all as provided below. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Stock” and the “Warrant Price,” respectively. This Warrant shall expire on the earliest of (i) 5:00 p.m., Pacific time, on March 24, 2010; (ii) the closing of the sale of the Company’s Common Stock pursuant to a registration statement filed by the Company under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the first underwritten offering of its securities to the general public (the “IPO”); or (iii) the effective date of a Change of Control (the “Termination Date”).
2. Definitions. As used in this Warrant, the following terms shall have the definitions ascribed to them below:
(a) The term “Change of Control” means (i) the acquisition of all or substantially all of the assets of the Company by another entity or (ii) the acquisition of the Company by another
entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation but excluding any sale of stock for capital raising purposes) that results in the voting securities of the Company outstanding immediately prior thereto failing to represent immediately after such transaction or series of transactions (either by remaining outstanding or by being converted into voting securities of the surviving entity or the entity that controls such surviving entity) a majority of the total voting power represented by the outstanding voting securities of the Company, such surviving entity or the entity that controls such surviving entity.
(b) The term “Warrant Price” means $3.00.
(c) The term “Warrant Stock” means the Company’s Common Stock or other stock or securities received in respect of, or in exchange for, the Common Stock.
3. Exercise.
(a) Exercise Procedure. This Warrant is exercisable immediately. This Warrant may be exercised by the Registered Holder, in whole or in part, by surrendering this Warrant, with the Notice of Exercise and the Investment Representation Statement in the forms attached hereto as Attachments 1 and 2, respectively, as duly executed by such Registered Holder or by such Registered Holder’s duly authorized attorney, at the principal office of the Company, or at such other office or agency as the Company may designate by notice to the Registered Holder, accompanied by payment of the Warrant Price payable in respect of the number of shares of Warrant Stock purchased upon such exercise.
(b) Effectiveness of Exercise. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which this Warrant shall have been surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name or names any certificates for Warrant Stock shall be issuable upon such exercise as provided in Section 3(d) below shall be deemed to have become the holder or holders of record of the Warrant Stock represented by such certificates.
(c) Net Issue Exercise.
(i) In lieu of exercising this Warrant in the manner provided above in Section 3(a), the Registered Holder may elect to receive shares of Warrant Stock equal to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with a Notice of Conversion in the form attached hereto as Attachment 3 in which event the Company shall issue to holder a number of shares of Warrant Stock computed using the following formula:
| X | = | Y (A - B) | ||
| A | ||||
| Where X | = | The number of shares of Warrant Stock to be issued to the Registered Holder. | ||
-2-
| Y | = | The number of shares of Warrant Stock purchasable under this Warrant or the portion thereof to be surrendered (at the date of such calculation). | ||
| A | = | The fair market value of one share of Warrant Stock (at the date of such calculation). | ||
| B | = | The Warrant Price (as adjusted to the date of such calculation). | ||
(ii) For purposes of this Section 3, the current fair market value of Warrant Stock, with respect to each share of Warrant Stock, shall mean:
(1) If the exercise is in connection with the IPO, the current fair market value shall be the “price to the public” of one share of Common Stock in the final prospectus.
(2) If the exercise is in connection with a Change of Control, the current fair market value shall be the per share value received by the holders of the Common Stock pursuant to the Change of Control, and the exercise shall be effective upon the closing of the Change of Control, subject to due, proper and prior surrender of this Warrant.
(3) Otherwise, the current fair market value shall be the highest price per share which the Company could obtain from a willing buyer (not a current employee or director) for shares sold by the Company from authorized but unissued shares of Common Stock as determined in good faith by its Board of Directors.
(d) Share Certificates. As soon as practicable after the exercise of this Warrant in full or in part, the Company at its expense will cause to be issued in the name of, and delivered to, the Registered Holder, or as such Registered Holder (upon payment by such Registered Holder of any applicable transfer taxes) may direct:
(i) a certificate or certificates for the number of shares of Warrant Stock to which such Registered Holder shall be entitled, with the following legends:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”), AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS (“BLUE SKY LAWS”). ANY TRANSFER OF SUCH SECURITIES WILL BE INVALID UNLESS A REGISTRATION STATEMENT UNDER THE ACT OR AS REQUIRED BY BLUE SKY LAWS IS IN EFFECT AS TO SUCH TRANSFER OR IN THE OPINION OF COUNSEL SATISFACTORY TO THE COMPANY SUCH REGISTRATION IS UNNECESSARY IN ORDER FOR SUCH TRANSFER TO COMPLY WITH THE ACT OR BLUE SKY LAWS.
-3-
THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A MARKET STAND-OFF AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL STOCKHOLDER THAT PROHIBITS SALE OR TRANSFER OF SUCH SHARES FOR A PERIOD OF UP TO 180 DAYS FOLLOWING THE DATE OF THE FINAL PROSPECTUS FOR THE INITIAL PUBLIC OFFERING OF THE ISSUER’S COMMON STOCK. THIS AGREEMENT IS BINDING UPON TRANSFEREES. A COPY OF THE AGREEMENT IS ON FILE WITH THE SECRETARY OF THE ISSUER.
Furthermore, the Company may place on each certificate any legend required by any applicable state blue sky law; and
(ii) in case such exercise is in part only, a new warrant or warrants of like tenor, calling in the aggregate on the face or faces thereof for the number of shares of Warrant Stock equal to the number of such shares called for on the face of this Warrant minus the number of such shares purchased by the Registered Holder upon such exercise as provided in Section 3(a) above.
4. Adjustments and Notices.
(a) Subdivision, Stock Dividends or Combinations. In case the Company shall at any time subdivide the outstanding shares of the Warrant Stock or shall issue a stock dividend with respect to the Warrant Stock, the Warrant Price in effect immediately prior to such subdivision or the issuance of such dividend shall be proportionately decreased, and in case the Company shall at any time combine the outstanding shares of the Warrant Stock, the Warrant Price in effect immediately prior to such combination shall be proportionately increased, effective at the close of business on the date of such subdivision, dividend or combination, as the case may be. When any adjustment is required to be made to the Warrant Price, the number of shares of Warrant Stock purchasable upon the exercise of this Warrant shall be changed to the number determined by dividing (i) an amount equal to the number of shares issuable upon the exercise of this Warrant immediately prior to such adjustment multiplied by the Warrant Price in effect immediately prior to such adjustment by (ii) the Warrant Price in effect immediately after such adjustment.
(b) Reclassification, Exchange, Substitution, In-Kind Distribution. Except with respect to a Change of Control, any reclassifications, exchange, substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant or upon the payment of a dividend in securities or property other than Warrant Stock, the Registered Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that the Registered Holder would have received for the Warrant Stock if this Warrant had been exercised immediately before the record date for such reclassification, exchange, substitution, or other event or immediately prior to the record date for such dividend. The Company or its successor shall promptly issue to the Registered Holder a new warrant for such new securities or other property. The new warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 4 including, without limitation, adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new warrant. The provisions of this Section 4(b)
-4-
shall similarly apply to successive reclassifications, exchanges, substitutions, or other events and successive dividends.
(c) No Impairment. The Company shall not, by amendment of its Certificate of Incorporation, as amended from time to time (the “Certificate”), or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all times in good faith assist in carrying out of all the provisions of this Section 4 and in taking all such action as may be necessary or appropriate to protect the Registered Holder’s rights under this Section 4 against impairment.
(d) Notice. Upon any adjustment of the Warrant Price and any increase or decrease in the number of shares of the Warrant Stock purchasable upon the exercise or conversion of this Warrant, then, and in each such case, the Company, as promptly as practicable thereafter, shall give written notice thereof to the Registered Holder of this Warrant at the address of such Registered Holder as shown on the books of the Company, which notice shall state the Warrant Price as adjusted and the increased or decreased number of shares purchasable upon the exercise or conversion of this Warrant, setting forth in reasonable detail the method of calculation of each. The Company further agrees to notify the Registered Holder of this Warrant in writing of a Change of Control at least ten (10) days prior to the effective date thereof. The Company also agrees to notify the Registered Holder of this Warrant in writing of the IPO at least ten (10) days prior to the effective date thereof.
5. No Stockholder Rights. This Warrant, by itself, as distinguished from any Warrant Stock purchased hereunder, shall not entitle the Registered Holder to any of the rights of a stockholder of the Company.
6. Transfer of Warrant. This Warrant may be transferred or assigned by the Registered Holder hereof in whole or in part, provided that (i) the transferor provides, at the Company’s request, an opinion of counsel satisfactory to the Company that such transfer does not require registration under the Securities Act and the securities law applicable with respect to any other applicable jurisdiction, (ii) the transferee agrees to execute all documents necessary to be bound by the terms of this Warrant and (iii) the Company, in its sole discretion, consents to such assignment or transfer. Notwithstanding the foregoing, this Warrant may be transferred by a Registered Holder which is a partnership to a limited or general partner of such partnership if (i) the transferee agrees in writing to be subject to the terms of this Warrant; (ii) the Registered Holder delivers written notice of such transfer to the Company and (iii) there are no more than five (5) transferees.
7. Registration Rights. The Registered Holder, with respect to the Warrant Stock issuable upon exercise of this Warrant, shall be entitled to certain registration rights upon entering into the Seventh Amended and Restated Registration Rights Agreement dated on or about February 2005, as amended, by and among the Company and the persons and entities listed on Exhibit A and Exhibit B thereto, and upon the terms and obligations set forth in such agreement.
-5-
8. Market Stand-off Agreement. The Registered Holder agrees in connection with the IPO that, upon request of the Company or the underwriters managing the IPO, not to sell, make any short sale of, loan, grant any option for the purchase of, pledge, hypothecate, limit such Registered Holder’s market risk regarding or otherwise directly or indirectly dispose of any Warrant Stock or other capital stock of the Company or securities exchangeable or convertible into capital stock of the Company without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed one hundred eighty (180) days from the date of the final prospectus used in such registration) as may be requested by the Company or such managing underwriters; provided, that the officers and directors of the Company who own stock or options of the Company also agree to such restrictions. The Registered Holder agrees to provide to such underwriters further agreements as such underwriters may reasonably request in connection with this market stand-off agreement, provided that the terms of such agreements are substantially consistent with this Section 8.
9. Reservation of Stock. The Company will at all times reserve and keep available, solely for the issuance and delivery upon the exercise of this Warrant, such shares of Warrant Stock as shall be issuable upon the exercise of this Warrant.
10. Replacement of Warrants. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new warrant of like tenor.
11. Mailing of Notices. Any notice required or permitted pursuant to this Warrant shall be in writing and shall be deemed sufficient when delivered personally or sent by telegram or fax or forty-eight (48) hours after being deposited in the U.S. mail, as certified or registered mail, with postage prepaid, addressed (a) if to the Registered Holder, to the address of the Registered Holder most recently furnished in writing to the Company and (b) if to the Company, to the address set forth below or subsequently modified by written notice to the Registered Holder.
12. No Fractional Shares. No fractional shares of Warrant Stock will be issued in connection with any exercise hereunder. In lieu of any fractional shares which would otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied by the fair market value of one share of Warrant Stock on the date of exercise, as determined in the same manner as described in Section 3(c)(ii).
13. Representations and Covenants of the Registered Holder. This Warrant has been entered into by the Company in reliance upon the following representations and covenants of the Registered Holder.
(a) Investment Purpose. The right to acquire Warrant Stock contained herein will be acquired for investment and not with a view to the sale or distribution of any part thereof, and the Registered Holder has no present intention of selling or engaging in any public distribution of the same except pursuant to a registration or exemption from registration.
-6-
(b) Private Issue. The Registered Holder understands (i) that the Warrant Stock issuable upon exercise of this Warrant is not registered under the Securities Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant will be exempt from the registration and qualifications requirements thereof, and (ii) that the Company’s reliance on such exemption is predicated on the representations set forth in this Section 13.
(c) Financial Risk. The Registered Holder has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its investment, and has the ability to bear the economic risks of its investment.
(d) Risk of No Registration. The Registered Holder understands that if the Company does not register with the Securities and Exchange Commission pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (the “1934 Act”), or file reports pursuant to Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the Securities Act is not in effect when the Registered Holder desires to sell (i) the rights to purchase Warrant Stock pursuant to this Warrant or (ii) the Warrant Stock issuable upon exercise of the right to purchase, it may be required to hold such securities for an indefinite period. The Registered Holder also understands that any sale of its rights to purchase Warrant Stock which might be made by it in reliance upon Rule 144 under the Securities Act may be made only in accordance with the terms and conditions of that Rule.
(e) Accredited Investor. Registered Holder is an “accredited investor” within the meaning of Rule 501 under the Securities Act, as presently in effect.
14. Amendment or Waiver. Any term of this Warrant may be amended or waived only by an instrument in writing signed by the party against which enforcement of the amendment or waiver is sought.
15. Headings. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of this Warrant.
16. Governing Law. This Warrant shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law. In case any provision of this Warrant shall be invalid, illegal, or unenforceable, the validity, legality and enforceability of the remaining provisions of this Warrant shall not in any way be affected thereby.
17. Severability. If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded from this Warrant, and the balance hereof shall be interpreted as if such provision were so excluded.
18. Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.
19. Delay and Omissions. No delay or forbearance by any party to this Warrant in exercising or enforcing its rights under this Warrant shall be deemed to constitute a waiver or release
-7-
of any rights of such party, and no inference shall be made that any party has waived or released any rights as a result of such party’s delay or forbearance in exercising or enforcing its rights under this Warrant.
20. Counterparts. This Warrant may be executed in any number of counterparts, each of which shall be an original, but all of which together shall be deemed to constitute one instrument.
21. Entire Agreement. Except as otherwise set forth herein, this Warrant constitutes the full and entire and agreement between the parties with regard to the subject matter hereof.
[This space intentionally left blank]
-8-
Placement Agent Agreement
Alien Technology Corporation & Advanced Equities, Inc.
IN WITNESS WHEREOF, this Warrant to Purchase Stock was executed as of this day of March 2005.
| ALIEN TECHNOLOGY CORPORATION | ||
| By: | ||
| Print Name: | ||
| Title: | ||
| Address: | 18220 Butterfield Blvd. | |
| Morgan Hill, CA 95037 | ||
| Acknowledged and Agreed: | ||
| AEI HOLDING CORPORATION | ||
| By: | ||
| Name: | ||
| Title: | ||
| Address: | 311 S. Wacker, Suite 1650 | |
| Chicago, IL 60606 | ||
1
Attachment 1
NOTICE OF EXERCISE
TO: ALIEN TECHNOLOGY CORPORATION
1. The undersigned hereby elects to purchase shares of the Warrant Stock of Alien Technology Corporation pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price in full, together with all applicable transfer taxes, if any.
2. Please issue a certificate or certificates representing said shares of Warrant Stock in the name of the undersigned or in such other name as is specified below:
___________________________________________
(Name)
___________________________________________
(Address)
| (Date) | (Name of Warrant Holder) | |||||
| By: | ||||||
| Title: | ||||||
-2-
Attachment 2
INVESTMENT REPRESENTATION STATEMENT
Warrant Stock (as defined in the attached Warrant)
of
ALIEN TECHNOLOGY CORPORATION
In connection with the purchase of the above-listed securities, the undersigned hereby represents to the Company as follows:
(a) The securities to be received upon the exercise of the Warrant (the “Securities”) will be acquired for investment for its own account, not as a nominee or agent, and not with a view to the sale or distribution of any part thereof, and the undersigned has no present intention of selling, granting participation in or otherwise distributing the same, but subject, nevertheless, to any requirement of law that the disposition of its property shall at all times be within its control. By executing this Statement, the undersigned further represents that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer, or grant participations to such person or to any third person, with respect to any Securities issuable upon exercise of the Warrant.
(b) The undersigned understands that the Securities issuable upon exercise of the Warrant at the time of issuance may not be registered under the Securities Act of 1933, as amended (the “Act”), and applicable state securities laws, on the ground that the issuance of such securities is exempt pursuant to Section 4(2) of the Act and state law exemptions relating to offers and sales not by means of a public offering, and that the Company’s reliance on such exemptions is predicated on the undersigned’s representations set forth herein.
(c) Except for a transfer by the undersigned, in the event the undersigned is a partnership, to a limited or general partner of such partnership, the undersigned agrees that in no event will it make a disposition of any Securities acquired upon the exercise of the Warrant unless and until (i) it shall have notified the Company of the proposed disposition and shall have furnished the Company with a statement of the circumstances surrounding the proposed disposition, and (ii) it shall have furnished the Company with an opinion of counsel satisfactory to the Company and Company’s counsel to the effect that (A) appropriate action necessary for compliance with the Act and any applicable state securities laws has been taken or an exemption from the registration requirements of the Act and such laws is available, and (B) the proposed transfer will not violate any of said laws.
(d) The undersigned acknowledges that an investment in the Company is highly speculative and represents that it is able to fend for itself in the transactions contemplated by this Statement, has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its investments, and has the ability to bear the economic risks (including the risk of a total loss) of its investment. The undersigned represents that it has had the opportunity to ask questions of the Company concerning the Company’s business and assets and to obtain any additional information which it considered necessary to verify the accuracy of or to amplify the Company’s disclosures, and has had all questions which have been asked by it satisfactorily answered by the Company.
-3-
(e) The undersigned acknowledges that the Securities issuable upon exercise of the Warrant must be held indefinitely unless subsequently registered under the Act or an exemption from such registration is available. The undersigned is aware of the provisions of Rule 144 promulgated under the Act which permit limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other things, the existence of a public market for the shares, the availability of certain current public information about the Company, the resale occurring not less than one year after a party has purchased and paid for the security to be sold, the sale being through a “broker’s transaction” or in transactions directly with a “market makers” (as provided by Rule 144(f)) and the number of shares being sold during any three-month period not exceeding specified limitations.
Dated:
| (Typed or Printed Name) | ||
| By: | ||
| (Signature) | ||
| (Title) | ||
-4-
Attachment 3
NOTICE OF CONVERSION
TO: ALIEN TECHNOLOGY CORPORATION
1. The undersigned hereby elects to acquire shares of the Warrant Stock of Alien Technology Corporation pursuant to the terms of the attached Warrant, by conversion of percent ( %) of the Warrant.
2. Please issue a certificate or certificates representing said shares of Securities in the name of the undersigned or in such other name as is specified below:
____________________________________
(Name)
____________________________________
(Address)
Dated:
| (Typed or Printed Name) | ||
| By: | ||
| (Signature) | ||
| (Title) | ||
-5-
